thymidylate synthase inhibitor DFP-11207
Term · Oncology and biomedicine · MLC-T-ONC-017155
An orally available thymidylate synthase (TS) inhibitor with potential antineoplastic activity. Upon oral administration, DFP-11207 binds to and inhibits TS. This reduces thymine nucleotide synthesis, inhibits DNA synthesis and cell division, causes DNA damage and leads to tumor cell apoptosis. TS catalyzes the conversion of deoxyuridine monophosphate (dUMP) to deoxythymidine monophosphate (dTMP).
| Identifier | MLC-T-ONC-017155 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | TS inhibitor DFP-11207 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-017155",
"term": "thymidylate synthase inhibitor DFP-11207",
"field": "Oncology and biomedicine",
"definition": "An orally available thymidylate synthase (TS) inhibitor with potential antineoplastic activity. Upon oral administration, DFP-11207 binds to and inhibits TS. This reduces thymine nucleotide synthesis, inhibits DNA synthesis and cell division, causes DNA damage and leads to tumor cell apoptosis. TS catalyzes the conversion of deoxyuridine monophosphate (dUMP) to deoxythymidine monophosphate (dTMP).",
"synonyms": [
"TS inhibitor DFP-11207"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/thymidylate-synthase-inhibitor-dfp-11207/"
}
Record 16,329 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.